Lorraine Zakin

Title: Lorraine Zakin: Innovator in Mucosal Therapeutics

Introduction

Lorraine Zakin is a prominent inventor based in Bois Colombes, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammation and inflammatory pain in mucosal areas. With a total of 2 patents to her name, Zakin's work is paving the way for innovative therapeutic solutions.

Latest Patents

Zakin's latest patents focus on the development of pharmaceutical compositions that utilize alpha-adrenergic receptor agonists. These inventions aim to prevent or treat inflammatory pain and diseases affecting the mucosa of the oral cavity, pharynx, and larynx. The first patent details a mucosal prolonged release bioadhesive therapeutic carrier designed for the controlled release of these agonists. The second patent similarly addresses the need for effective treatment options in mucosal surfaces, emphasizing the importance of bioadhesive slow-release carriers.

Career Highlights

Lorraine Zakin is currently associated with Onxeo S.A., a company dedicated to developing innovative therapies for cancer and other serious diseases. Her work at Onxeo has been instrumental in advancing mucosal therapeutic options, showcasing her commitment to improving patient care through innovative solutions.

Collaborations

Zakin collaborates with notable colleagues, including Pierre Attali and Caroline Lemarchand. These partnerships enhance her research and development efforts, contributing to the success of her innovative projects.

Conclusion

Lorraine Zakin's contributions to mucosal therapeutics highlight her role as a leading inventor in the pharmaceutical industry. Her innovative patents and collaborations reflect her dedication to advancing medical science and improving treatment options for patients.